Sartorius Stedim Biotech Stock Börse Stuttgart
Stocks
56S1
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Börse Stuttgart
15:56:35 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 214.80 EUR | +2.29% |
|
-3.23% | +2.09% |
| 10-06 | Option Care Health deal boosts European medical equipment makers |  |
| 10-06 | Option Care Health deal boosts European medical equipment makers | |
| Market Cap | 21B 23.65B 19.65B 17.81B 33.63B 2,280B 33.88B 236B 91.79B 1,163B 88.78B 86.88B 3,739B | P/E 2026 * |
55.3x | P/E 2027 * | 42.7x |
|---|---|---|---|---|---|
| Enterprise Value | 23.01B 25.92B 21.53B 19.51B 36.86B 2,498B 37.12B 259B 101B 1,275B 97.28B 95.2B 4,097B | EV / Sales 2026 * |
7.36x | EV / Sales 2027 * | 6.55x |
| Free-Float |
28.47% | Yield 2026 * |
0.38% | Yield 2027 * | 0.47% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| DIM | Real-time | |
CBOE
| DIMp | Real-time | |
|
Tradegate
| 56S1 | Real-time | |
|
Xetra
| 56S1 | Delayed | |
|
OTC Markets
| SDMHF | Delayed | |
|
Boerse Muenchen
| 56S1 | Real-time | |
|
Börse Stuttgart
| 56S1 | Delayed | |
|
Deutsche Boerse AG
| 56S1 | Delayed | |
|
London S.E.
| 0NK7 | Delayed | |
|
CBOE
| 0NK7 | Real-time | |
|
Borsa Italiana
| 4DIM | End-of-day quote | |
|
Wiener Boerse
| DIM | End-of-day quote |
Last Transcript: Sartorius Stedim Biotech
| 1 week | -1.10% | ||
| Current month | +1.42% | ||
| 1 month | +12.28% | ||
| 3 months | +20.00% | ||
| 6 months | +24.96% | ||
| Current year | +4.42% |
| 1 week | 205 |  | 224 |
| 1 month | 182.4 | | 224 |
| 3 years | 139.8 | | 279.1 |
| 5 years | 139.8 | | 533.6 |
| 10 years | 51.12 | | 557.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 70 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.29% | -3.23% | +9.09% | -4.15% | 22.9B | |
| -1.94% | -2.79% | -27.07% | +2.04% | 173B | |
| -1.00% | -2.69% | -10.86% | +14.37% | 113B | |
| -2.46% | +1.05% | -24.91% | +5.06% | 109B | |
| +1.52% | +0.41% | -48.13% | -10.00% | 74.44B | |
| +0.46% | +4.13% | +4.50% | +70.97% | 60.1B | |
| -0.43% | +7.25% | +18.14% | +67.16% | 51.87B | |
| -0.20% | -1.92% | -6.87% | -30.93% | 49.21B | |
| -2.21% | -2.58% | -18.34% | +19.72% | 41.52B | |
| -4.04% | -3.80% | +24.37% | -0.73% | 32.79B | |
| Average | -0.73% | +0.62% | -8.01% | +13.35% | 78.34B | |
| Weighted average by Cap. | -0.91% | +0.42% | -15.25% | +11.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.52B 2.93B 2.65B 5.01B 340B 5.05B 35.15B 13.67B 173B 13.23B 12.94B 557B | 3.48B 3.91B 3.25B 2.95B 5.57B 377B 5.61B 39.06B 15.19B 193B 14.7B 14.38B 619B |
| Net income | 377M 425M 353M 320M 605M 40.98B 609M 4.24B 1.65B 20.91B 1.6B 1.56B 67.21B | 483M 544M 452M 410M 773M 52.43B 779M 5.43B 2.11B 26.75B 2.04B 2B 85.98B |
| Net Debt | 2.01B 2.26B 1.88B 1.71B 3.22B 218B 3.24B 22.6B 8.79B 111B 8.5B 8.32B 358B | 1.76B 1.99B 1.65B 1.5B 2.83B 192B 2.85B 19.83B 7.71B 97.73B 7.46B 7.3B 314B |
| Date | Price | Change |
|---|---|---|
| 26-10-06 | €214.80 | +2.29% |
| 26-10-05 | €210.00 | +0.29% |
| 26-10-02 | €209.40 | +1.45% |
| 26-10-01 | €206.40 | -2.55% |
| 26-09-30 | €211.80 | -2.49% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
- 56S1 Stock
Select your edition
All financial news and data tailored to specific country editions
